U.S., Jan. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07379255) titled 'Evaluation of Postoperative Adjuvant Chemotherapy Efficacy for Bladder Cancer Based on Organoid Technology.' on Jan. 23.
Brief Summary: To evaluate the clinical efficacy of using tumor organoid drug sensitivity experiments to guide postoperative adjuvant chemotherapy in patients with muscle-invasive bladder cancer, and to assess the application value of tumor organoid drug sensitivity experiments in guiding individualized postoperative adjuvant chemotherapy for muscle-invasive bladder cancer.
Study Start Date: Jan. 01, 2025
Study Type: OBSERVATIONAL
Condition:
Bladder Cancer
Intervention:
OTHER: Organoid culture
Organoid cult...